These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. How important is the second dose of the COVID-19 mRNA vaccine? Liu AY J Allergy Clin Immunol Pract; 2021 Jun; 9(6):2537. PubMed ID: 34112480 [No Abstract] [Full Text] [Related]
9. Skin ulcer at the injection site of BNT162b2 mRNA COVID-19 vaccine. Aoki N; Saruta Y; Tanaka S; Nakajima R; Sano H; Sano S J Dermatol; 2021 Dec; 48(12):e596-e597. PubMed ID: 34545609 [No Abstract] [Full Text] [Related]
10. Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine. Skowronski DM; De Serres G N Engl J Med; 2021 Apr; 384(16):1576-1577. PubMed ID: 33596348 [No Abstract] [Full Text] [Related]
11. Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine. Reply. Absalon J; Koury K; Gruber WC N Engl J Med; 2021 Apr; 384(16):1578. PubMed ID: 33596351 [No Abstract] [Full Text] [Related]
12. Comparison of BNT162b2 (Pfizer-BioNtech) and mRNA-1273 (Moderna) SARS-CoV-2 mRNA vaccine immunogenicity in dialysis patients. Kaiser RA; Haller MC; Apfalter P; Kerschner H; Cejka D Kidney Int; 2021 Sep; 100(3):697-698. PubMed ID: 34270945 [No Abstract] [Full Text] [Related]
13. Experience with SARS-CoV-2 BNT162b2 mRNA vaccine in dialysis patients. Yanay NB; Freiman S; Shapira M; Wishahi S; Hamze M; Elhaj M; Zaher M; Armaly Z Kidney Int; 2021 Jun; 99(6):1496-1498. PubMed ID: 33887318 [No Abstract] [Full Text] [Related]
14. Delayed cutaneous reactions after the administration of mRNA vaccines against COVID-19. Juárez Guerrero A; Domínguez Estirado A; Crespo Quirós J; Rojas-Pérez-Ezquerra P J Allergy Clin Immunol Pract; 2021 Oct; 9(10):3811-3813. PubMed ID: 34293500 [No Abstract] [Full Text] [Related]
15. First-Dose mRNA COVID-19 Vaccine Allergic Reactions: Limited Role for Excipient Skin Testing. Wolfson AR; Robinson LB; Li L; McMahon AE; Cogan AS; Fu X; Wickner P; Samarakoon U; Saff RR; Blumenthal KG; Banerji A J Allergy Clin Immunol Pract; 2021 Sep; 9(9):3308-3320.e3. PubMed ID: 34166844 [TBL] [Abstract][Full Text] [Related]
16. Acute Perimyocarditis Following First Dose of mRNA Vaccine Against COVID-19. Vollmann D; Eiffert H; Schuster A Dtsch Arztebl Int; 2021 Aug; 118(31-32):546. PubMed ID: 34515024 [No Abstract] [Full Text] [Related]
17. Delayed Large Local Reactions to mRNA-1273 Vaccine against SARS-CoV-2. Blumenthal KG; Freeman EE; Saff RR; Robinson LB; Wolfson AR; Foreman RK; Hashimoto D; Banerji A; Li L; Anvari S; Shenoy ES N Engl J Med; 2021 Apr; 384(13):1273-1277. PubMed ID: 33657292 [No Abstract] [Full Text] [Related]
18. BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting. Roest S; Hoek RAS; Manintveld OC N Engl J Med; 2021 May; 384(20):1968-1970. PubMed ID: 33882226 [No Abstract] [Full Text] [Related]
19. Accelerate Coronavirus Disease 2019 (COVID-19) Vaccine Rollout by Delaying the Second Dose of mRNA Vaccines. Plotkin SA; Halsey N Clin Infect Dis; 2021 Oct; 73(7):1320-1321. PubMed ID: 33502467 [No Abstract] [Full Text] [Related]
20. BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting. Reply. Barda N; Dagan N; Balicer RD N Engl J Med; 2021 May; 384(20):1970. PubMed ID: 33882227 [No Abstract] [Full Text] [Related] [Next] [New Search]